Prediction of HIV acquisition among men who have sex with men.
OBJECTIVE
To develop and validate an easy-to-use prediction model for HIV acquisition among men who have sex with men (MSM).


METHODS
We developed prediction models using medical records data from an STD clinic (2001-2008) and validated these models using data from the control arm of Project Explore, an HIV prevention trial (1999-2003).


RESULTS
Of 1903 MSM who tested for HIV more than once in the development sample, 101 acquired HIV over 6.7 years of follow-up. Annual HIV incidence was 2.57% (95% confidence interval [CI]: 2.09%, 3.12%). During 4 years of follow-up of 2081 Project Explore control arm participants, 144 acquired HIV for an incidence of 2.32% (95% CI: 1.96%, 2.73%). A prediction model that included variables indicating use of methamphetamine or inhaled nitrites in the prior 6 months, unprotected anal intercourse with a partner of positive or unknown HIV status in the prior year, > or =10 male sex partners in the prior year, and current diagnosis or history of bacterial sexually transmitted infection was well calibrated overall (expected-observed ratio = 1.01; 95% CI: 0.97, 1.05) and had modest discriminatory accuracy at 1 year (area under the receiver-operator characteristic curve = 0.67; 95% CI: 0.60, 0.75) and at 4 years (area under the receiver-operator characteristic curve = 0.66; 95% CI: 0.61, 0.71). Over 4 years, cumulative incidence ranged from 3.9% to 14.3% for groups of men defined by the prediction model.


CONCLUSIONS
A new risk score was predictive of HIV acquisition and could assist providers in counseling MSM and in targeting intensified prevention to MSM at greatest risk for HIV infection. Its accuracy requires further evaluation.
Menza
Timothy W
TW
Center for AIDS and STD, University of Washington, Harborview Medical Center, 325 Ninth Ave., Seattle, WA 98104, USA. menza@u.washington.edu
Hughes
James P
JP
Celum
Connie L
CL
Golden
Matthew R
MR
D000328:Adult; D019969:Amphetamine-Related Disorders / Q000150:complications; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000635:transmission*; D018451:Homosexuality, Male; D006801:Humans; D015994:Incidence; D008297:Male; D008499:Medical Records; D008694:Methamphetamine; D015233:Models, Statistical; D011237:Predictive Value of Tests; D012307:Risk Factors; D012309:Risk-Taking; D012725:Sexual Behavior; D012747:Sexual Partners; D012749:Sexually Transmitted Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000635:transmission; D047568:Unsafe Sex; D055815:Young Adult
D008694:Methamphetamine
Circulation. 2002 Dec 17;106(25):3143-421
12485966
Ann Intern Med. 2007 Apr 3;146(7):511-5
17404353
Pharmacotherapy. 2004 Jan;24(1):69-78
14740789
MMWR Morb Mortal Wkly Rep. 2008 Sep 12;57(36):985-9
18784639
Ann Intern Med. 2006 Feb 7;144(3):201-9
16461965
Am J Epidemiol. 2004 May 1;159(9):882-90
15105181
Hypertension. 2003 Dec;42(6):1206-52
14656957
Am J Public Health. 1993 Apr;83(4):520-4
8460727
JAMA. 2008 Aug 6;300(5):520-9
18677024
JAMA. 2001 Jul 11;286(2):180-7
11448281
Lancet. 1999 Jan 9;353(9147):89-92
10023892
Ann Intern Med. 1999 Mar 16;130(6):515-24
10075620
AIDS. 2006 Nov 14;20(17):2193-7
17086059
J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86
2593165
PLoS Med. 2007 Dec;4(12):e339
18052602
Biometrics. 2005 Mar;61(1):92-105
15737082
J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):734-42
15167293
N Engl J Med. 2006 Dec 21;355(25):2615-7
17182986
J Infect Dis. 2002 Oct 1;186(7):1019-22
12232844
Am J Public Health. 2007 Jun;97(6):1067-75
17463384
J Addict Dis. 2002;21(1):91-105
11831503
AIDS. 2006 Mar 21;20(5):731-9
16514304
Circulation. 2006 Aug 15;114(7):e257-354
16908781
J Acquir Immune Defic Syndr. 2005 May 1;39(1):82-9
15851918
Diabetes Care. 2007 Jan;30 Suppl 1:S48-65
17192379
Chest. 2003 Jan;123(1 Suppl):83S-88S
12527567
J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):489-95
16010174
J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):202-10
12394799
Ann Intern Med. 2008 Mar 4;148(5):337-47
18316752
AIDS. 2005 Aug 12;19(12):1323-5
16052089
J Acquir Immune Defic Syndr. 2007 May 1;45(1):85-92
17325605
Stat Med. 1996 Feb 28;15(4):361-87
8668867
JAMA. 1998 Oct 7;280(13):1161-7
9777816
Am J Epidemiol. 2006 Oct 15;164(8):733-41
16896053
Int J Cancer. 2007 Jan 1;120(1):1-6
17058200
BMJ. 2001 Jun 16;322(7300):1451-6
11408300
Stat Med. 1998 Jan 30;17(2):219-38
9483730
Am J Public Health. 1998 Jan;88(1):113-6
9584015
J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):76-85
11782594
Lancet. 2004 Jul 3-9;364(9428):41-50
15234855
Sex Transm Dis. 2004 Aug;31(8):475-80
15273580
Med J Aust. 1989 Jun 5;150(11):634-9
2725377
Am J Epidemiol. 2006 Apr 1;163(7):676-83
16484448
Am J Public Health. 2007 Jun;97(6):1060-6
17463370
J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):373-9
11707675
Sex Transm Dis. 1998 Nov;25(10):539-43
9858350
Diabetes Metab Res Rev. 2000 May-Jun;16(3):164-71
10867715
Biometrics. 2000 Jun;56(2):337-44
10877287
Am J Epidemiol. 1997 Oct 1;146(7):531-42
9326430
JAMA. 2001 Jun 13;285(22):2864-70
11401607
Sex Transm Dis. 1992 Mar-Apr;19(2):61-77
1595015
BMJ. 1999 Dec 11;319(7224):1562-5
10591726